TRUIST FINANCIAL CORP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2021$89,000
-72.2%
25,500
-21.5%
0.00%
-100.0%
Q1 2021$320,000
-9.1%
32,5000.0%0.00%0.0%
Q4 2020$352,000
+5.1%
32,5000.0%0.00%0.0%
Q3 2020$335,000
+3.4%
32,500
+109.7%
0.00%0.0%
Q2 2020$324,000
+114.6%
15,5000.0%0.00%
Q1 2020$151,000
-15.6%
15,5000.0%0.00%
Q4 2019$179,00015,5000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders